Dubai, United Arab Emirates

Ivan Castelino

This inventor holds 1 USPTO granted patent. Top assignee: Siemens Logistics LLC. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ivan Castelino: Innovator in Conveyor System Monitoring

Introduction

Ivan Castelino is a notable inventor based in Dubai, AE. He has made significant contributions to the field of conveyor systems, particularly in monitoring their operational conditions. His innovative approach aims to enhance the efficiency and reliability of these systems, especially in critical environments like airports.

Latest Patents

Ivan Castelino holds a patent for a "System and method for condition monitoring during the operation of a conveyor system." This invention focuses on a method that includes conveyor units and a background system designed to monitor the condition of conveyor systems, specifically airport baggage conveyors. The system allows for the recording of individual current characteristics of conveyor units, enabling the detection of impending wear or malfunctions.

Career Highlights

Ivan is currently employed at Siemens Logistics LLC, where he applies his expertise in developing advanced solutions for conveyor systems. His work is instrumental in ensuring that these systems operate smoothly and efficiently, thereby improving overall operational performance.

Collaborations

Ivan collaborates with talented professionals such as Arun Kumar Unnikrishna Karnaver and Harsha Kallayya Mathad. Their combined efforts contribute to the innovative projects at Siemens Logistics LLC.

Conclusion

Ivan Castelino's contributions to conveyor system monitoring exemplify the importance of innovation in enhancing operational efficiency. His patent and work at Siemens Logistics LLC reflect a commitment to advancing technology in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…